|
⚲
|
| NGN Biomed 2A | |
|---|---|
| Firm |
NGN Capital LLC
✚
|
| Fund # | 805-8873822956 |
| CIK # | 0001422818 |
| Sale | 2007-12-14 ($350.0 MM Offered, $173.2 MM Sold) |
| Fund | Venture Capital Fund |
| Phone | 2129720077 |
| Address | 369 Lexington Ave, 17th Floor New York, 10017 |
| Source | [EDGAR] [IAPD] |
| Fund AUM and Sold ($) |
|---|
| Fund Details | |
|---|---|
| Director | NGN Biomed II GP LP |
| Custodian | |
| Auditor | RSM US LLP, Grant Thornton LLP |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2019 |
|---|---|
| NGN Biomed II GP LP | |
| NGN Capital LLC |
| Comparable Firms | State | AUM ($BB) |
|---|---|---|
|
Sizemore Capital Management LLC
✚
|
0.1 | |
|
Huesler Financial Consulting AG
✚
|
0.1 | |
|
Orasis Capital
✚
|
0.1 | |
|
Canaccord Genuity Wealth Management USA Inc
✚
|
0.1 | |
|
Maimon Wealth Management Ltd
✚
|
0.1 | |
|
Equilibrium Wealth LLC
✚
|
0.1 | |
|
Burren Capital Advisors Limited
✚
|
0.1 | |
|
Pacifica Partners Capital Management Inc
✚
|
0.1 | |
|
Rubin Overseas Ltd
✚
|
0.1 | |
|
Ormonde USA LLC
✚
|
0.1 |